Animal-based pharmaceutical firm Ashish Life Sciences (ALS) has raised $6.3m in funding. The investment was led by the Indian venture arm of Eight Roads, with support from Anterra Capital. Haven comes from global animal health firm Zoetis while Juergen has held senior executive positions at Nexvet Biopharma (acquired by Zoetis in 2017), Novartis Animal Health (acquired by Elanco in 2015) and Elanco. ALS will use the funding to scale its business in its existing markets and accelerate its plans to expand into Europe, Australia and South Africa. “India is a very important market for us,” said CEO Anand Agarwal.
Animal-based pharmaceutical firm Ashish Life Sciences (ALS) has raised $6.3m in funding. The investment was led by the Indian venture arm of Eight Roads, with support from Anterra Capital. ALS will use the funding to scale its business in its existing markets and accelerate its plans to expand into Europe, Australia and South Africa. “India is a very important market for us,” said CEO Anand Agarwal.